- January 22, 2020
- Category: Healthcare and LifeSciences, Medical Diagnostics
Global Non-Opioid Pain Treatment Market Size study, by Product (Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived), by Application (Orthopaedic and Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Others) and Regional Forecasts 2020-2027
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million) 1.2.1. Non-Opioid Pain Treatment Market, by Region, 2018-2027 (USD Million) 1.2.2. Non-Opioid Pain Treatment Market, by Product, 2018-2027 (USD Million) 1.2.3. Non-Opioid Pain Treatment Market, by Application, 2018-2027 (USD Million) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Non-Opioid Pain Treatment Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Non-Opioid Pain Treatment Market Dynamics 3.1. Non-Opioid Pain Treatment Market Impact Analysis (2018-2027) 3.1.1. Market Drivers 3.1.2. Market Challenges 3.1.3. Market Opportunities Chapter 4. Global Non-Opioid Pain Treatment Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Non-Opioid Pain Treatment Market, by Product 5.1. Market Snapshot 5.2. Global Non-Opioid Pain Treatment Market by Product, Performance - Potential Analysis 5.3. Global Non-Opioid Pain Treatment Market Estimates & Forecasts by Product 2017-2027 (USD Million) 5.4. Non-Opioid Pain Treatment Market, Sub Segment Analysis 5.4.1. Medical Cannabis 5.4.2. Menthol-Containing 5.4.3. Omega 3 Fatty Acid-Containing 5.4.4. Botulinum Toxins 5.4.5. Capsaicin-Derived Chapter 6. Global Non-Opioid Pain Treatment Market, by Application 6.1. Market Snapshot 6.2. Global Non-Opioid Pain Treatment Market by Application, Performance - Potential Analysis 6.3. Global Non-Opioid Pain Treatment Market Estimates & Forecasts by Application 2017-2027 (USD Million) 6.4. Non-Opioid Pain Treatment Market, Sub Segment Analysis 6.4.1. Orthopaedic and Musculoskeletal Pain 6.4.2. Neuropathic Pain 6.4.3. Cancer Pain 6.4.4. Others Chapter 7. Global Non-Opioid Pain Treatment Market, Regional Analysis 7.1. Non-Opioid Pain Treatment Market, Regional Market Snapshot 7.2. North America Non-Opioid Pain Treatment Market 7.2.1. U.S. Non-Opioid Pain Treatment Market 126.96.36.199. Product breakdown estimates & forecasts, 2017-2027 188.8.131.52. Application breakdown estimates & forecasts, 2017-2027 7.2.2. Canada Non-Opioid Pain Treatment Market 7.3. Europe Non-Opioid Pain Treatment Market Snapshot 7.3.1. U.K. Non-Opioid Pain Treatment Market 7.3.2. Germany Non-Opioid Pain Treatment Market 7.3.3. France Non-Opioid Pain Treatment Market 7.3.4. Spain Non-Opioid Pain Treatment Market 7.3.5. Italy Non-Opioid Pain Treatment Market 7.3.6. Rest of Europe Non-Opioid Pain Treatment Market 7.4. Asia-Pacific Non-Opioid Pain Treatment Market Snapshot 7.4.1. China Non-Opioid Pain Treatment Market 7.4.2. India Non-Opioid Pain Treatment Market 7.4.3. Japan Non-Opioid Pain Treatment Market 7.4.4. Australia Non-Opioid Pain Treatment Market 7.4.5. South Korea Non-Opioid Pain Treatment Market 7.4.6. Rest of Asia Pacific Non-Opioid Pain Treatment Market 7.5. Latin America Non-Opioid Pain Treatment Market Snapshot 7.5.1. Brazil Non-Opioid Pain Treatment Market 7.5.2. Mexico Non-Opioid Pain Treatment Market 7.6. Rest of The World Non-Opioid Pain Treatment Market Chapter 8. Competitive Intelligence 8.1. Top Market Strategies 8.2. Company Profiles 8.2.1. Medropharm Gmbh 184.108.40.206. Key Information 220.127.116.11. Overview 18.104.22.168. Financial (Subject to Data Availability) 22.214.171.124. Product Summary 126.96.36.199. Recent Developments 8.2.2. US Worldmeds LLC 8.2.3. Centrexion Therapeutics Corp. 8.2.4. Tilray, Inc. 8.2.5. GW Pharmaceuticals, plc 8.2.6. Allergan plc 8.2.7. Cronos Group 8.2.8. Medical Marijuana, Inc. 8.2.9. Cara Therapeutics, Inc. 8.2.10. Canopy Growth Corporation Chapter 9. Research Process 9.1. Research Process 9.1.1. Data Mining 9.1.2. Analysis 9.1.3. Market Estimation 9.1.4. Validation 9.1.5. Publishing 9.2. Research Attributes 9.3. Research Assumption
Global Non-Opioid Pain Treatment Market is valued at approximately USD 13.8 million in 2019 and is anticipated to grow with a healthy growth rate of more than 18% over the forecast period 2020-2027. Non-opioid pain treatment is the complementary to the opioids treatment which are increasingly used for the mild to moderate pain. Non opioids pain treatment is regularly taken with or without remedy that is over the counter (OTC) drugs. This treatment method are often robust pain relievers. They typically opt in the place of opioids due to its increase addiction triggered by opioids. For acute pain, non-opioid drugs are ideal to provide effective health benefits and first-line treatment and are available in over the counter and prescription formulations. This has led to a rise in demand for non-opioid treatment all over the world. Moreover, the increasing prevalence of chronic diseases such as cancer in the developed & developing countries, along with the rising research and developmental (R&D) efforts associated with non-opioid treatment for pain relief are few other factors responsible for the market growth over the forecast period. As per the International Agency for Research on Cancer (IARC), around 17.0 million new cancer cases were registered in 2018, with overall 9.5 million cancer deaths around the world. As per the IARC, the global prevalence of cancer is also expected to grow to over 27.5 million new cancer cases and 16.3 million cancer deaths by the year 2040. This, in turn, is expected to accelerate the demand for Non-Opioid Pain Treatment around the world. Recently, the COVID-19 is widely spread throughout the world, thus various regional governments are mandating the use of several drugs among the patients for disease management and/or to prevent the spread of COVID-19. This is likely to positively impact the growth of the non-opioid pain treatment drugs market. However, the presence for alternative therapies and counterfeit products is one of the major factors impeding the market growth over the forecast period of 2020-2027.
The regional analysis of the global Non-Opioid Pain Treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the undergoing clinical trials and funding for R&D of novel drug therapies, along with the presence of significant number of manufacturers in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rising prevalence of chronic diseases, along with the changing economic demographic which improve drug affordability would create lucrative growth prospects for the Non-Opioid Pain Treatment market across the Asia-Pacific region.
Major market player included in this report are:
US Worldmeds LLC
Centrexion Therapeutics Corp.
GW Pharmaceuticals, plc
Medical Marijuana, Inc.
Cara Therapeutics, Inc.
Canopy Growth Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Omega 3 Fatty Acid-Containing
Orthopaedic and Musculoskeletal Pain
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Non-Opioid Pain Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers